Nomenclature
CAS number: 7246-21-1
α-Ethyl-2,4,6-triiodo-3-[(1-oxobutyl)amino]benzenepropanoic
acid monosodium salt; 3-butyramido-α-ethyl-2,4,6-triiodohydrocinnamic acid sodium
salt; α-ethyl-β-(2,4,6-triiodo-3-butyramidophenyl)propionic acid
sodium salt; sodium tyropanoate; Win-8851-2; Bilopaque (Sterling Winthrop); Lumopaque (Winthrop); Tyropaque (Torii).
C
15H
17I
3NNaO
3; mol wt 663.00.
C 27.17%, H 2.58%, I 57.42%, N 2.11%, Na 3.47%, O 7.24%.
Description and references
Prepn: S. Archer, J. O. Hoppe, US 2895988 (1959 to Sterling Drug); and pharmacology: J. O. Hoppe et al., J. Med. Chem. 13, 997 (1970).
Clinical trials: S. Y. Han, D. M. Witten, Radiology 112, 529 (1974); R. F. Thoeni, A.
A. Moss, ibid. 144, 271 (1982).
Properties
Colorless solid from ethyl ether, mp 208-210°. Soluble in water. LD50 i.v. in mice:
720 mg/kg (Hoppe).Derivative
Free acid.
C
15H
18I
3NO
3; mol wt 641.02.
C 28.11%, H 2.83%, I 59.39%, N 2.19%, O 7.49%.
Properties
Crystals from ethyl oxyacetate, mp 182-184°.Therapeutic Category
Diagnostic aid (radiopaque medium—cholecystographic).
Keywords
Diagnostic Aid (Radiopaque Medium)